Global Oncology Academy

Poster Pearl: Detecting Cancer with an MCED Test and Treating It Surgically Improves Outcomes

ReachMD Healthcare Image
RestartResume

Dive into the findings from a poster presented at the 2023 American Society of Clinical Oncology Annual Meeting.

  • Overview

    A poster presented at the 2023 American Society of Clinical Oncology Annual Meeting unveiled key findings from the longitudinal analysis on the DETECT-A study. One such finding was that patients who underwent surgery after their cancer was detected by a blood-based multi-cancer early detection (MCED) test had more positive outcomes compared to those who received treatment with chemotherapy, radiation therapy, or a kinase inhibitor. Learn more about these long-term clinical outcomes with Dr. Charles Turck and Mr. Adam Buchanan, Associate Professor and Chair of the Department of Genomic Health at Geisinger in Danville, Pennsylvania and co-author of the poster.

    This is a non-certified educational program produced and controlled by ReachMD and is intended for healthcare professionals only. This program discusses a technology under development. Any features discussed describe current development goals. It has not been cleared or approved by the U.S. FDA or any other national regulatory authority.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free